[Caixin Global] Brand-name drugs feel the squeeze in China’s generic-heavy market
Release Date:
Multinational pharmaceutical firms are changing strategies and selling business lines, as a government bulk-buying program favors cheaper, local products.Click here to read the article by Tang Hanyu and Kelly Wang.Narrated by Elyse Ribbons.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
[Caixin Global] Brand-name drugs feel the squeeze in China’s generic-heavy market